Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,682 | 7 | 75.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,865 | 1 | 19.6% |
| Travel and Lodging | $1,058 | 4 | 4.3% |
| Food and Beverage | $280.10 | 8 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim International GmbH | $12,425 | 10 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $4,865 | 1 | $0 (2024) |
| AstraZeneca UK Limited | $3,696 | 1 | $0 (2020) |
| Daiichi Sankyo Company LTD | $1,530 | 1 | $0 (2020) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $981.00 | 3 | $0 (2019) |
| Renalytix AI, Inc. | $750.00 | 1 | $0 (2022) |
| Travere Therapeutics, Inc. | $627.13 | 2 | $0 (2023) |
| Gilead Sciences, Inc. | $11.55 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,290 | 11 | Boehringer Ingelheim International GmbH ($12,425) |
| 2023 | $27.13 | 1 | Travere Therapeutics, Inc. ($27.13) |
| 2022 | $1,350 | 2 | Renalytix AI, Inc. ($750.00) |
| 2020 | $5,226 | 2 | AstraZeneca UK Limited ($3,696) |
| 2019 | $992.55 | 4 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($981.00) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| 11/04/2024 | IDORSIA PHARMACEUTICALS US INC | Tryvio (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,865.00 | General |
| Category: Hypertension | ||||||
| 08/09/2024 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $8,600.00 | General |
| 08/09/2024 | Boehringer Ingelheim International GmbH | — | Food and Beverage | In-kind items and services | $68.24 | General |
| 08/09/2024 | Boehringer Ingelheim International GmbH | — | Travel and Lodging | In-kind items and services | $64.24 | General |
| 07/19/2024 | Boehringer Ingelheim International GmbH | — | Travel and Lodging | In-kind items and services | $431.86 | General |
| 07/19/2024 | Boehringer Ingelheim International GmbH | — | Travel and Lodging | In-kind items and services | $358.40 | General |
| 07/19/2024 | Boehringer Ingelheim International GmbH | — | Travel and Lodging | In-kind items and services | $203.81 | General |
| 07/19/2024 | Boehringer Ingelheim International GmbH | — | Food and Beverage | In-kind items and services | $54.54 | General |
| 07/19/2024 | Boehringer Ingelheim International GmbH | — | Food and Beverage | In-kind items and services | $21.82 | General |
| 07/19/2024 | Boehringer Ingelheim International GmbH | — | Food and Beverage | In-kind items and services | $21.82 | General |
| 05/25/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $27.13 | General |
| 10/11/2022 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 04/15/2022 | Renalytix AI, Inc. | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 12/30/2020 | Daiichi Sankyo Company LTD | — | Consulting Fee | Cash or cash equivalent | $1,530.00 | General |
| 08/21/2020 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $3,695.50 | General |
| 12/09/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | JYNARQUE (Drug) | Consulting Fee | Cash or cash equivalent | $906.00 | General |
| Category: NEPHROLOGY | ||||||
| 11/10/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: NEPHROLOGY | ||||||
| 11/10/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: NEPHROLOGY | ||||||
| 04/14/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.55 | General |
About Dr. John He, MD
Dr. John He, MD is a Nephrology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740217538.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John He, MD has received a total of $24,885 in payments from pharmaceutical and medical device companies, with $17,290 received in 2024. These payments were reported across 20 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($18,682).
Practice Information
- Specialty Nephrology
- Location Bronx, NY
- Active Since 06/27/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1740217538
Products in Payments
- Tryvio (Drug) $4,865
- JYNARQUE (Drug) $981.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Bronx
Dr. Bruce Spinowitz, M.d, M.D
Nephrology — Payments: $510,667
Joel Neugarten, Md, MD
Nephrology — Payments: $384,806
Enver Akalin, M.d, M.D
Nephrology — Payments: $76,364
Abdurhman Ahmed, M.d, M.D
Nephrology — Payments: $12,466
Dr. Suman Reddy, Md, MD
Nephrology — Payments: $7,783
Mr. Joseph Bonanno, D.o, D.O
Nephrology — Payments: $7,333